Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 7Neoplasms 2Weight Loss 1Prostatic Neoplasms 1Polyps 1Osteoporosis 1Myocardial Ischemia 1Myocardial Infarction 1Metabolic Syndrome 1Heart Diseases 1Diabetes Mellitus 1Depression 1Coronary Disease 1Colonic Neoplasms 1Cognitive Dysfunction 1Cardiovascular Diseases 1Carcinoma, Renal Cell 1Bone Diseases 1Body Weight Changes 1Angina, Unstable 1Adenoma 1

Interventions

Metformin 2Ethinyl Estradiol 2Blood Pressure 2drospirenone and ethinyl estradiol combination 1drospirenone 1Vascular Stiffness 1Ultrasonography 1Triptorelin Pamoate 1Testosterone 1Sugars 1Spironolactone 1Pulse Wave Analysis 1Preoperative Exercise 1Phlebotomy 1Orchiectomy 1Medical History Taking 1Magnetic Resonance Spectroscopy 1Inositol 1Human Growth Hormone 1Hematologic Tests 1Growth Hormone 1Flutamide 1Exercise 1Etanercept 1Electrocardiography 1Echocardiography 1Diet, Reducing 1Diet, Mediterranean 1Diet, Fat-Restricted 1Diet Therapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metabolic Syndrome × Diet, Fat-Restricted × Clear all
NCT00924937 2021-06-03

CORDIOPREV

Hospital Universitario Reina Sofia de Cordoba

Phase NA Completed
1,002 enrolled

Angina, Unstable, Diabetes Mellitus, Myocardial Infarction, Neoplasms, Metabolic Syndrome, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡